Selexis CHO Cells in Suspension-1

Archives 2014

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

DECEMBER 9, 2014
1 min read

Symphogen A/S Licenses the Selexis SUREtechnology Expression Platform and Cell Line

Geneva, Switzerland, December 9, 2014 – Selexis SA, a serial innovation company with proven technologies for biologic...

Read More
JULY 30, 2014
1 min read

Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference

Data addresses key issues associated with effective translation, translocation and secretion of therapeutic proteins in...

Read More
JUNE 24, 2014
2 min read

Cook Pharmica, LLC and Selexis SA Establish Customized Biologic Drug Development and Manufacturing Services Platform

Preliminary Data from the Successful Proof-of-Concept Program Published in the June Issue of BioProcess International

...

Read More
JUNE 5, 2014
1 min read

Selexis SA to Showcase Revolutionary Advancements in Protein Expression Technologies at BIO 2014

Selexis to Meet with Biopharmaceutical Companies Interested in Protein Drug Discovery, Mammalian Cell Line Development...

Read More
MAY 30, 2014
1 min read

Selexis SA CEO to Speak at the BioProcess Theater at BIO 2014

Dr. Igor Fisch to Present Data on Using Genome Engineering and the Selexis SURE CHO-Mplus Libraries for Optimal...

Read More
APRIL 23, 2014
1 min read

Selexis SA to Speak on Overcoming Complex Difficult-to-Express ProteinSecretion Bottlenecks at the 2014 Protein Engineering Summit (PEGS)

Company CSO to Present Data on the Selexis SURE CHO-Mplus™ Libraries

Geneva, Switzerland, April 23 2013 – Selexis SA, a...

Read More
MARCH 26, 2014
1 min read

Selexis SA to Speak at the the Human Antibodies and Hybridomas (HAH2014) Conference

Dr. Pierre-Allain Girod to Present on Data on Engineering CHO Cell Lines for Enhanced Production of Monoclonal...

Read More
FEBRUARY 27, 2014
2 min read

"Pre-Clinical Advancements to Reduce Attrition Rates in Biologic Drug Discovery"

A Webinar Hosted by Selexis SA

Selexis CSO Demonstrates How the Selexis SURE CHO-Mplus™ Libraries Can Dramatically...

Read More
FEBRUARY 25, 2014
1 min read

Selexis SA to Partner at BIO-Europe Spring

Selexis to Meet with Biopharmaceutical Companies Interested in Protein Drug Discovery, Cell Line Development and Lead...

Read More
FEBRUARY 20, 2014
1 min read

Selexis Announces Expansion of R&D License Agreement with Amgen

Expansion to Include the Selexis SURE CHO-M Cell Line™

Geneva, Switzerland (PRNEWSWIRE) February 20, 2013 – Selexis SA,...

Read More
JANUARY 13, 2014
2 min read

Opthea Signs Cell Line Development Commercial License Agreement with Selexis SA for Wet AMD Product

Geneva, Switzerland, January 13, 2014 – Selexis SA, a serial innovation company focused on drug discovery for lead...

Read More